cobalt has been researched along with ginsenoside rg1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, C; Duan, J; Jiang, Q; Li, KR; Yao, J; Zhang, ZQ; Zhao, YX | 1 |
| Cheng, Z; Hong, C; Ling, C; Liu, T; Qin, J; Ren, H; Wang, J; Zhang, M; Zhu, Y | 1 |
2 other study(ies) available for cobalt and ginsenoside rg1
| Article | Year |
|---|---|
Ginsenoside Rg-1 protects retinal pigment epithelium (RPE) cells from cobalt chloride (CoCl2) and hypoxia assaults.
Topics: Apoptosis; Cell Hypoxia; Cell Line; Cell Survival; Cobalt; Cytoprotection; Enzyme Activation; Ginsenosides; Humans; Mechanistic Target of Rapamycin Complex 1; Mitogen-Activated Protein Kinases; Multiprotein Complexes; Reactive Oxygen Species; Retinal Pigment Epithelium; TOR Serine-Threonine Kinases | 2013 |
Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Cobalt; Ginsenosides; Male; Myeloid Differentiation Factor 88; Neuroprotective Agents; NF-kappa B; Panax; PC12 Cells; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury; Sirtuin 1; Toll-Like Receptor 4 | 2019 |